Absence of influence of the Korean MELD score-based liver allocation system on pretransplant MELD score in patients undergoing living donor liver transplantation
- Affiliations
-
- 1Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Abstract
- Background
Model for end-stage liver disease (MELD) score-based allocation system was started in 2016 in Korea. This study aimed to analyze the profiles of adult patients who underwent living donor liver transplantation (LDLT) in the pre- and post-MELD eras.
Methods
This study was a retrospective double-arm analysis using a single-institution LDLT cohort. We compared the LDLT recipient profiles by focusing on pretransplant MELD score for 4 years before and after the introduction of the MELD score-based allocation system. Patients without and with hepatocellular carcinoma (HCC) were categorized as groups A and B in the preMELD era and groups C and D in the post-MELD era, respectively.
Results
The number of patients in groups A, B, C and D was 615, 599, 704, and 713, respectively; and their MELD scores were 19.0±9.4, 11.2±5.6, 17.9±8.5, and 11.6±5.7, respectively. Clinical parameters of liver cirrhosis indicate that group A had worse general conditions than group C; and groups B and D had similar general conditions. The comparative analysis between groups A and C revealed the mean and median MELD scores as 19.0±9.4 and 17.9±8.5 (P=0.009), and 16 and 15 (P=0.077), respectively.
The comparative analysis between groups B and D revealed the mean and median MELD scores as 11.2±5.6 and 11.6±5.7 (P=0.14), and 9 and 9 (P=0.14), respectively.
Conclusions
Median pretransplant MELD score was in the range of 15–16 in LDLT recipients without HCC and nine in those with HCC. Introduction of MELD score in deceased donor organ allocation system resulted in a marginal decrease in the pretransplant MELD score in patients undergoing LDLT without HCC, but no change in those with HCC.